Regulacje i polityka gospodarcza · 08/10/1997

Government-Owned Inventions; Availability for Licensing

The National Institutes of Health is seeking licensees for the further development, evaluation, and commercialization of novel progesterone antagonists and pharmaceutical compositions thereof. The invention claimed in U.S. Patent Application 60/016,628 entitled ``21- Substituted Progesterone Derivatives As New Antiprogestational Agents'' (HK Kim, RP Blye, PN Rao, JW Cessac, and CK Acosta), filed May 1, 1996, and a related case filed April 30, 1997, are available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404).